PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Wall Street ends down as oil prices, Treasury yields rise
PerkinElmer (PKI) PT Raised to $175 at Stifel Following EPS and BioLegend Deal
July 27, 2021 6:18 AM EDTStifel analyst Daniel Arias raised the price target on PerkinElmer (NYSE: PKI) to $175.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "Yesterday, PKI announced another acquisition (the company's 7th announced since Horizon in Nov '20 - though by far the... More
